Reported 6 months ago
The article discusses the recent decline in Walgreens Boots Alliance stock, which has reached its lowest level since 1998, down over 45% in the past year and over 75% in the past decade. The company has faced challenges due to reimbursement pressures in the pharmacy industry, leading to a significant write-down on its investment in VillageMD. The new CEO is looking to shift reimbursements to a cost-plus model, but the turnaround process may take time. With an inexpensive valuation and potential for recovery, the stock may be an option for patient investors willing to tolerate risk.
Source: YAHOO